UC San Diego Scientists Unveil Potentially Game-Changing Treatment for Severe Fatty Liver Disease Using Experimental Drug ION224
UC San Diego researchers report that the experimental drug ION224 achieves unprecedented reductions in liver fat and inflammation in MASH patients, potentially transforming treatment for a disease affecting hundreds of millions worldwide.